Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine.

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort  Michèle Beau-Faller, MD,
Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract  Noah Switzer, Andrew Lim, Lillian Du,
Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive.
Volume 370, Issue 9605, Pages (December 2007)
Volume 67, Issue 1, Pages (January 2015)
The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study  Ying Li, Sheng Zhang, Xi.
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.
Volume 105, Issue 3, Pages (March 1994)
Volume 195, Issue 5, Pages (May 2016)
Volume 18, Issue 6, Pages e1 (November 2017)
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Oncol Res Treat 2016;39: DOI: /
The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.
Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Volume 52, Issue 3, Pages (September 2007)
European Urology Oncology
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk.
The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy  Olaf A. Brinkmann,
Volume 68, Issue 1, Pages (July 2015)
Volume 67, Issue 1, Pages (January 2015)
Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer  Lee.
Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data  Kathleen Lang,
Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy 
The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR- Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors 
Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study  Thomas K. Eigentler, Ulrike Leiter, Hans-Martin Häfner,
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Volume 155, Issue 5, Pages (November 2018)
Case series of 21 patients with extrahepatic metastatic lobular breast carcinoma to the gastrointestinal tract  Noah Switzer, Andrew Lim, Lillian Du,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients: A Brief Report  Benjamin Nisman, PhD, Hovav.
Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest  Christopher Lau, MD, Padraic O’Malley, MD, Mario.
Volume 151, Issue 1, Pages (October 2018)
Hashem B. El-Serag, Thomas P
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Relevance of Platinum-Sensitivity Status in Relapsed/Refractory Extensive-Stage Small- Cell Lung Cancer in the Modern Era: A Patient-Level Analysis of.
Volume 7, Issue 11, (November 2010)
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD 
Renal risk scores: Progress and prospects
Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy  Todd.
Does Granulocyte Colony–Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer?  Goulnar Kasymjanova, MD, Harvey Kreisman,
Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung Cancer  Yoichi Nakamura, MD, PhD, Kazumi Sano, PhD, Hiroshi.
Volume 147, Issue 1, Pages (October 2017)
PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered?  Steven G. Gray, PhD  Journal of Thoracic.
Thoracoscopic Lobectomy Produces Long-Term Survival Similar to That with Open Lobectomy in Cases of Non–Small Cell Lung Carcinoma: A Propensity-Matched.
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.
Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304)  Gregory A. Otterson,
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
Impact of a Multidisciplinary Thoracic Oncology Clinic on the Timeliness of Care  Richard F. Riedel, MD, Xiaofei Wang, PhD, Meg McCormack, PA-C, Eric Toloza,
Volume 152, Issue 1, Pages (January 2019)
Renal Pyelocalyceal Squamous Cell Carcinoma
It’s All in the “Swerve of the Curve”
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark 
Interferon alfa-2a for melanoma metastases
Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J
Clinical Lymphoma, Myeloma and Leukemia
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
Volume 64, Issue 4, Pages (October 2003)
Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non–Small- Cell Lung Cancer  Jih-Hsiang Lee, MD, Yu-Lin Lin, MD, Wei-Hsun Hsu,
Volume 163, Issue 2, (October 2015)
Impact of Immunotherapy after Resection of Pancreatic Cancer
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W
Presentation transcript:

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors  Pawel Chrom, Rafal Stec, Aleksandra Semeniuk-Wojtas, Lubomir Bodnar, Nathaniel J. Spencer, Cezary Szczylik  Clinical Genitourinary Cancer  Volume 14, Issue 5, Pages 457-464 (October 2016) DOI: 10.1016/j.clgc.2016.02.005 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Kaplan-Meier Curve for Overall Survival for the Whole Patient Cohort Clinical Genitourinary Cancer 2016 14, 457-464DOI: (10.1016/j.clgc.2016.02.005) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Kaplan-Meier Curves for Overall Survival Stratified by Risk Group Clinical Genitourinary Cancer 2016 14, 457-464DOI: (10.1016/j.clgc.2016.02.005) Copyright © 2016 The Authors Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.